Biopharmaceutical industry has made much progress over the past 20 years, with a wide range of biopharmaceuticals being developed. These biopharmaceuticals specifically include amino acids and their derivatives, peptides, monoclonal antibodies, recombinant proteins, PEGylated proteins, vaccines, oligonucleotides, glycoproteins, biosimilars, and so on. Before clinical study, the biological activity or potency of the biomolecules has to be defined to guarantee its drug efficacy. However, the complexity of biopharmaceuticals often presents challenge to assess the structure, heterogeneity, aggregation, physicochemical properties, stability and impurities, etc. With extensive experience and capabilities in biopharmaceutical research, Creative Proteomics provides comprehensive biopharmaceutical analysis services, tailored specifically for the research and manufacturing of protein biotherapies, including early detection, process optimization, and pharmacokinetic/pharmacodynamic (PK/PD) research.
Our biopharmaceutical service mainly covers the following services:
Experts from Creative Proteomics are always on hand to provide scientific and technical support coupled with project management and timely report to drive your development and manufacturing programs forward. We follow the principles of analysis of identity, purity, quantity, as well as product- and process-related safety and efficacy in accordance with the ICH Q6B guidelines of technical requirements for biotechnological/biological products.
Our advantages:
- High quality biopharmaceutical analysis (following ICH Q6B guidelines)
- Customized analysis services
- Timely, professional and detailed reports
